Physician profile
Sandeep Gupta
NPI 1720055379
$45,840.83
in general payments reported to CMS, 2019-2025
27 companies · $6,147 in 2025
The $6,147 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,523 · 2020: $3,402 · 2021: $6,203 · 2022: $6,649 · 2023: $8,927 · 2024: $9,989 · 2025: $6,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $15K · Food and Beverage: $9,618 · Debt Forgiveness: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $14,604.62 |
| Food and Beverage | $9,618.15 |
| Debt Forgiveness | $840.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18,389.52 | 2019-2025 | Farapulse, Rhythmia Mapping System, Watchman Access System |
| Abbott Laboratories | $11,010.74 | 2019-2025 | Ensite, Ensite Precision, Agilis |
| Medtronic, INC. | $7,428.07 | 2021-2025 | Pulseselect |
| Medtronic Vascular, INC. | $4,218.44 | 2019-2020 | |
| Lantheus Medical Imaging, INC. | $840.00 | 2023 | Definity |
| Zoll Respicardia, INC. | $667.96 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $488.94 | 2019-2020 | |
| Atricure, INC. | $376.94 | 2024 | |
| Kestra Medical Technology Services, INC. | $354.09 | 2024-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $306.04 | 2019-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $290.63 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $249.97 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $214.56 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $191.03 | 2021 | |
| Janssen Scientific Affairs, LLC | $124.99 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $104.44 | 2021 | |
| Amgen INC. | $89.98 | 2019 | |
| Biotronik INC. | $79.96 | 2023 | Acticor 7 Vr-T Dx |
| Pfizer INC. | $77.61 | 2019 | |
| Cardiva Medical, INC. | $73.21 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cardiofocus, INC. | $70.15 | 2020 | |
| Sanofi-Aventis U.S. LLC | $61.89 | 2019 | |
| Sunovion Pharmaceuticals INC. | $37.18 | 2019 | |
| Philips North America LLC | $36.60 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.53 | 2024 | Jardiance |
| Merck Sharp & Dohme LLC | $19.29 | 2025 | Winrevair |
| Bard Peripheral Vascular, INC. | $16.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.